Related Experiment Video

Updated: Sep 26, 2026

Lighting Up the Pathways to Caspase Activation Using Bimolecular Fluorescence Complementation
08:47

Lighting Up the Pathways to Caspase Activation Using Bimolecular Fluorescence Complementation

Published on: March 5, 2018

Therapeutic activation of caspases in cancer: a question of selectivity

Pierre Beauparlant1, Gordon C Shore

  • 1Gemin X Biotechnologies Inc, 3576 Avenue du Parc, Suite 4310, Montreal, Quebec, H2X 2H7, Canada. pbeauparlant@geminx.com

Current Opinion in Drug Discovery & Development
|April 3, 2003
PubMed

Insights

New therapeutic agents targeting programmed cell death (apoptosis) offer novel cancer treatment strategies. These agents modulate key apoptosis regulators, potentially enhancing cancer cell death and overcoming resistance to conventional therapies.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Caspase activation is a key indicator of programmed cell death (apoptosis).
  • Apoptosis is a regulated cellular process with therapeutic intervention potential.
  • Conventional therapies trigger apoptosis via cellular stress sensors.

Purpose of the Study:

  • To explore novel therapeutic agents that modulate key apoptosis regulators.
  • To investigate the clinical utility of new apoptosis-modulating drugs.
  • To assess the potential of these agents in cancer treatment, alone or in combination.

Main Methods:

  • Review of emerging therapeutic agents targeting apoptosis.
  • Analysis of small molecule mimetics and synthetic ligands.
  • Evaluation of drug mechanisms, including Bcl-2 inhibition and Smac agonism.

Main Results:

  • Identification of novel agents like Bcl-2 inhibitors, Smac mimetics, and death receptor ligands.
  • Demonstration of these agents' ability to modulate apoptosis.
  • Potential for selective induction of apoptosis in cancer cells.

Conclusions:

  • New therapeutic agents targeting apoptosis regulators show clinical promise.
  • These agents can selectively induce apoptosis in cancer cells.
  • They may sensitize resistant cancer cells to conventional cytotoxic agents, improving treatment outcomes.

More Related Videos

Measuring Caspase Activity Using a Fluorometric Assay or Flow Cytometry05:29

Measuring Caspase Activity Using a Fluorometric Assay or Flow Cytometry

Published on: March 24, 2023

Evaluation of Caspase Activation to Assess Innate Immune Cell Death10:23

Evaluation of Caspase Activation to Assess Innate Immune Cell Death

Published on: January 20, 2023

Related Concept Videos

Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...